SILENT MOVING PICKS

[miltonjayro]

London Pacific & Partners, Inc. LDPP Bid .0024 Ask .004

10Q JUST RELEASED AUG 21 2011 http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=58614

Asset: $29.5 million, Liabilities: 1 million. Stock Holders Equity: $28.5 million

Share Structure
Market Value1 $281,535 a/o Jun 30, 2011
Shares Outstanding 93,845,130 a/o Apr 30, 2011
Float 19,043,307 a/o Apr 30, 2011
Authorized Shares 200,000,000 a/o Apr 30, 2011
Par Value 0.001

Contact Info

2301 Rosecrans Avenue
Suite 3180
El Segundo, CA, 90245
Website: http://www.londonpacificgroup.com

Phone: [phone]
Email: [e-mail]

Business Description

With offices in Los Angeles, Salt Lake City, London and Mumbai, London Pacific & Partners, Inc. is an international private equity and corporate finance investor and advisor focused on the transformation of undervalued and growth companies in the healthcare, hospitality, and financial services sectors. The Company's website address is www.londonpacificgroup.com.


London Pacific & Partners to Consider Preparation of Appeal of Regulatory Ruling Regarding Acquisition of Healthcare System in Brazil and Completion of Acquisition of Ana Costa
Apr 29, 2011

OTC Disclosure & News Service

El Segundo, CA -

LONDON PACIFIC & PARTNERS, INC. (PINK SHEETS: LDPP) (“London Pacific”), the international investment and management advisor, announced that the Sellers of Ana Costa , who have been in the process of seeking approval to transfer the licenses of Santos Adminstracao e Participacoes S.A., (“Ana Costa”) to an affiliate of London Pacific by ANS for over a year, have notified the Company that the license transfer by Nacional de Saude Suplementar (“ANS”), has been denied. Ana Costa is a private healthcare system, located in Santos, Brazil, comprised of three hospitals, eight clinics and an HMO health insurance plan.



London Pacific plans to consider an appeal to the ruling made by ANS denying the license transfer as well as to consider continuing its work with the Sellers of Ana Costa to complete the transaction.


Commenting on the ruling by ANS, Stuart Bruck, Executive Chairman of London Pacific, said, “We look forward to working towards a solution with the Sellers of Ana Costa including determining the best path to successfully appealing the recent decision by ANS. We believe that London Pacific has responded adequately to the ANS and the Sellers of Ana Costa and have provided the requested information in a reasonable and appropriate manner. Based on information received thus far, the Company believes that with ANS approval, completion of this transaction can still be pursued and looks forward to working with the Sellers of Ana Costa to complete the deal as planned.

May 25, 2011 Attorney Letter with Respect to Current Information
http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=52090

May 16, 2011 Quarterly Report Mar 31, 2011 Active
http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=51077

OTC Disclosure Current
http://www.otcmarkets.com/stock/LDPP/financials

London Pacific & Partners, Inc. Has Four Synergistic Businesses:
1. HealthcareMORE

London & Pacific Healthcare (Los Angeles)
London & Pacific Healthcare Ventures
City & Westminster Advisers (London)
Yen Healthcare Advisors (Mumbai)

A BUSINESS MODEL WITH A THREE-FOLD INVESTMENT OPPORTUNITY

When do you have the opportunity to invest in one company, and profit from three companies at the same time?
With London & Pacific's subsidiaries, you can do just that.

1. HealthSPAC LLC acts as an incubator for Special Purpose Acquisition Companies (SPACs), which are "blank check" companies that go public with the intention of merging or acquiring a company with the proceeds of an IPO. London & Pacific eventually sells off each SPAC equity interest. HealthSPAC recently raised $5 million from Equus Total Return, Inc. (NYSE: EQS) to fuel its SPAC focused exclusively on opportunities in the explosive pharmaceutical services sector.

2. City & Westminster Advisers Limited provides comprehensive strategic and financial advisory services, successfully executing large M & A transactions and growth strategies for a number of companies.

3. And the newest addition to the family- Healthcare Fund Advisors, LLC leverages its parent's extensive network of financial resources, regulatory and management know-how to provide specialized buy-side sourcing and analysis services to clients that invest in the global healthcare sector.

What makes all of this a company ready to explode on the scene?

FIVE POINTS TO CONSIDER:

1. LDPP TARGETS THE $4 TRILLION GLOBAL HEALTHCARE INDUSTRY

2. LDPP IS LED BY AN ASTUTE TEAM OF DOCTORS AND GLOBAL HEALTHCARE EXECUTIVES

3. LDPP CREATES HUGE VALUE THROUGH SPECIALIZED IPOS

4. LDPP HAS MULTIPLE SUBSIDIARIES THAT MAXIMIZE THE REVENUE STREAM

5. LDPP IS UNHEARD OF BY INVESTORS .....MAKING THIS A GROUNDFLOOR OPPORTUNITY FOR THE SAVVY INVESTOR

LONDON & PACIFIC HAS HAD MAJOR SUCCESS IN ALL OF THEIR PREVIOUS VENTURES.
SEE FOR YOURSELF>>>>>


CASE STUDIES

London -BasedyHealthcare Company
Founded London-based healthcare company.
Raised £750k ($1.35m) in private fund raising and then launched AIM listing on the London Stock Exchange at a market capitalization of £6.75m ($12.15m).
Increased Company market share to 55% of occupational healthcare products sold in the UK through acquisition of four additional companies.
Original investors contributed $350,000 in the period 1998 to 2000 and have thus far earned more than $9m in cash and are significant shareholders in the company.


Southeastern US-Based Healthcare Service Company
This company is a producer and distributor of innovative medical office-based treatments for cancer.
Developed business plan and assisted client with required management changes.
Secured working capital and obtained SEC approval for listing as a public company.

Community Hospital in Southern California
Client is a general acute care hospital in Southern California that was closed by its parent company, based on perceived continued financial losses and excess hospital service capacity within the market area.
Retained by community group to advise on and later to assist with their acquiring and reopening the facility; performed required financial and clinical feasibility studies; strategized with Hospital Board.
Negotiated with the City to extend land and building lease to community group at $1/year and to extend a loan to the hospital; obtained hospital equipment from original owner at no cost to client.
Secured $11m credit line, despite lack of facility operating history; obtained more than $3m in charitable contributions.
Reopened hospital despite being shuttered for one year; hospital is now in its fifth year of successful operation.

"The reasons I like this stock is its share structure and chart looks for a reversal , 52 week bottom is .0021, with success of SKZW and other low floaters we can se this move with a strong group , I think we load first get as much as we can and then slowly get this going , radio silent , acquisition of Brazil account can be catalyst and speculative , the ss is current as per last filing I have watched this for 2 weeks and no mm games the Level 2 is good IMHO , set small blocks on way up."

A stock we can compare this too is UYMG recently went from .003 -.02 range as of late, LDPP has a better ss and financials are better imho:

COMPARISON UYMG and LDPP :

UYMG went from .003-.0275


ss Share Structure
Market Value1 $1,166,009 a/o Jul 07, 2011
Shares Outstanding 103,186,620 a/o Mar 31, 2011
Float 43,439,460 a/o Jun 30, 2010
Authorized Shares 240,000,000 a/o Mar 31, 2011
Par Value 0.001

:LDPP .0036 Share Structure



Market Value1 $337,842 a/o Jul 07, 2011
Shares Outstanding 93,845,130 a/o Apr 30, 2011
Float 19,043,307 a/o Apr 30, 2011
Authorized Shares 200,000,000 a/o Apr 30, 2011
Par Value 0.001